Yann Mazabraud
Corporate Officer/Principal presso RHYTHM PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Posizioni attive di Yann Mazabraud
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/10/2020 | - |
Storia della carriera di Yann Mazabraud
Precedenti posizioni note di Yann Mazabraud
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2017 | 03/10/2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2016 | 01/10/2017 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formazione di Yann Mazabraud
| Groupe de Sup de Co La Rochelle | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Francia | 2 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Graduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Yann Mazabraud
- Esperienza
